1 |
Neufeld, G., T. Cohen, S. Gengrinovitch, and A. Poltorak. 1999. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J. 13, 9-22
DOI
|
2 |
Nickoloff, B. J., R. S. Mitra, J. Varani, V. M. Dixit, and P. J. Polverini. 1994. Aberrant production of interleukin-8 and thrombospondin-1 by psoriatic keratinocytes mediates angiogenesis. Am. J. Pathol. 44, 820-828
|
3 |
Pal, S., M. L. Iruela-Arispe, V. S. Harvey, H. Zeng, J. A. Nagy, H. F. Dvorak, and D. Mukhopadhyay. 2000. Retinoic acid selectively inhibits the vascular permeabilizing effect of VPF/VEGF, an early step in the angiogenic cascade. Microvasc. Res. 60, 112-120
DOI
ScienceOn
|
4 |
Senger, D. R., K. P. Claffey, J. E. Benes, and C. A. Perruzzi, A. P. Sergiou, and M. Detmar. 1997. Angiogenesis promoted by vascular endothelial growth factor: regulation through alpha1beta1 and alpha2beta1 integrins. Proc. Natl. Acad. Sci.
USA 94, 13612-13617
DOI
ScienceOn
|
5 |
Weninger, W., M. Rendl, M. Mildner, and E. Tschachler. 1998. Retinoids downregulate vascular endothelial growth factor/vascular permeability factor production by normal human keratinocytes. J. Invest. Dermatol. 111, 907-911
DOI
ScienceOn
|
6 |
Kini, A. R., L. A. Peterson, M. S. Tallman, and M. W. Lingen. 2001. Angiogenesis in acute promyelocytic leukemia: induction by vascular endothelial growth factor and inhibition by all-trans retinoic acid. Blood 97, 3919-3924
DOI
ScienceOn
|
7 |
Koch, A. E., P. J. Polverini, S. L. Kunkel, L. A. Harlow, L. A. DiPietro, V. M. Elner, S. G. Elner, and R. M. Strieter. 1992. Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science 58, 1798-1801
|
8 |
Kuroda, K., A. Sapadin, T. Shoji, R. Fleischmajer, and M. Lebwohl. 2001. Altered expression of angiopoietins and Tie2 endothelium receptor in psoriasis. J. Invest. Dermatol. 116, 713-720
DOI
ScienceOn
|
9 |
Lachgar, S., M. Charveron, Y. Gall, and J. L. Bonafe. 1999. Inhibitory effects of retinoids on vascular endothelial growth factor production by cultured human skin keratinocytes. Dermatology 199, 25-27
DOI
ScienceOn
|
10 |
Lansink, M, P. Koolwijk, V. van Hinsbergh, and T. Kooistra. 1998. Effect of steroid hormones and retinoids on the formation of capillary-like tubular structures of human microvascular endothelial cells in fibrin matrices is related to urokinase expression. Blood 92, 927-938
|
11 |
Larcher, F., R. Murillas, M. Bolontrade, C. J. Conti, and J. L. Jorcano. 1998. VEGF/VPF overexpression in skin of transgenic mice induces angiogenesis, vascular hyperpermeability and accelerated tumor development. Oncogene
17, 303-311
DOI
ScienceOn
|
12 |
Diaz, B. V., M. C. Lenoir, A. Ladoux, C. Frelin, M. Demarchez, and S. Michel. 2000. Regulation of vascular endothelial growth factor expression in human keratinocytes by retinoids. J. Biol. Chem. 275, 642-650
DOI
ScienceOn
|
13 |
Lingen, M. W., P. J. Polverini, and N. P. Bouck. 1996. Retinoic acid induces cells cultured from oral squamous cell carcinomas to become anti-angiogenic. Am. J. Pathol. 149, 247-258
DOI
ScienceOn
|
14 |
Mordovtsev, V. N. and V. I. Albanova. 1989. Morphology of skin microvasculature in psoriasis. Am. J. Dermatopathol. 11, 33-42
DOI
ScienceOn
|
15 |
Detmar, M., K. T. Yeo, J. A. Nagy, L. Van de Water, L. F. Brown, B. Berse, B. M. Elicker, S. Ledbetter, and H. F. Dvorak. 1995. Keratinocyte-derived vascular permeability factor (vascular endothelial growth factor) is a potent mitogen for dermal microvascular endothelial cells. J. Invest. Dermatol. 105, 44-50
DOI
ScienceOn
|
16 |
Dvorak, H. F., L. F. Brown, M. Detmar, and A. M. Dvorak. 1995. Vascular permeability factor/ vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am. J. Pathol. 146, 1029-1039
|
17 |
Edward, R. S., N. Mark, C. W. James, K. S. Andres, L. Samuel, and H. Meenhard. 1999. Vascular endothelial growth factor is a marker of tumor invasion and metastasis in squamous cell carcinomas of the head and neck. Clin. Cancer Res. 5, 775-782
|
18 |
Ferrara, N. 1999. Role of vascular endothelial growth factor in the regulation of angiogenesis. Kidney Int. 56, 794-814
DOI
ScienceOn
|
19 |
Folkman, J. and M. Klagsburn. 1987. Angiogenic factors. Science 235, 442-447
DOI
|
20 |
Gille, J., M. Khalik, V. Konig, and R. Kaufmann. 1998. Hepatocyte growth factor/scatter factor (HGF/SF) induces vascular permeability factor (VPF/VEGF) expression by cultured keratinocytes. J. Invest. Dermatol. 111, 1160-1165
DOI
ScienceOn
|
21 |
Gottlieb, A. B. 1997. Immunopathogenesis of psoriasis. Arch. dermatol. 133, 781-782
DOI
ScienceOn
|
22 |
Ishikawa, F, K. Miyazono, and U. Hellman. 1989. Identification of anangiogenic activity and the cloning and expression of platelet derived endothelial cell growth factor. Nature 338, 557-562
DOI
ScienceOn
|
23 |
Braunhut, S. J. and M. A. Moses. 1994. Retinoids modulate endothelial cell production of matrix-degrading proteases and tissue inhibitors of metalloproteinases (TIMP). J. Biol. Chem. 269, 13472-13479
|
24 |
Braverman, I. M. and A. Keh-Yen. 1986. Three-dimensional reconstruction of endothelial cell gaps in psoriatic vessels and their morphologic identity with gaps produced by the intradermal injection of histamine. J. Invest. Dermatol. 86, 577-581
DOI
ScienceOn
|
25 |
Camacho, L. H. 2003. Clinical applications of retinoids in cancer medicine. J. Biol. Regul. Homeost. Agents. 17, 98-114
|
26 |
Christopher, F. and G. G. Krueger. 1987. Psoriasis. pp. 461-491, In Fitzpatrick, T. B., A. Z. Eisen, and D. Wolff (eds.), Dermatology in general medicine, 3rd ed, MaGraw-Hill Book, New York
|
27 |
Christophers, E., R. Parzefall, and O. Braun-Falco. 1973. Initial events in psoriasis: quantitative assessment. Br. J. Dermatol. 89, 327-334
DOI
ScienceOn
|
28 |
Detmar, M., L. F. Brown, K. P. Claffey, K. T. Yeo, O. Kocher, R. W. Jackman, B. Berse, and H. F. Dvorak. 1994. Overexpression of vascular permeability factor/vascular endothelial growth factor and its receptors in psoriasis. J. Exp. Med. 180, 1141-1146
DOI
ScienceOn
|
29 |
Berse, B., L. F. Brown, L. Van De Water, H. F. Dvorak, and D. R. Senger. 1992. Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors. Mol. Biol. Cell 3, 211-220
DOI
ScienceOn
|
30 |
Anderson, T. F. and J. Woorhees. 1986. Psoriasis. pp. 67-84, In Thiers, B. and W. Dobson (eds.), Pathogenesis of skin disease. McGraw-Hill book, New York
|